Galaxy Medicare IPO
Galaxy Medicare Limited
Minimum investment
Galaxy Medicare IPO Details
Bidding date
10 Sep - 12 Sep 2025
Price range
₹51 - ₹54
Minimum quantity
4,000
Minimum investment
₹1,02,000
Issue size
₹22.31 Cr.
IPO doc (link)
RHP docsListing exchange
NSE/BSE
Galaxy Medicare IPO Dates & Timeline
Galaxy Medicare IPO Subscription Status
Category | Subscription |
|---|---|
Qualified Institutional Buyers | - |
Retail Individual Investor | - |
Non-Institutional Investor | - |
Others | - |
Total | - |
About Galaxy Medicare IPO: Company Overview
Incorporated in July 1992, Galaxy Medicare Limited is a healthcare-focused company engaged in the manufacturing and export of medical devices, plaster of Paris (POP) bandages, and surgical dressings. The company uses premium-grade raw materials sourced from trusted vendors to ensure superior quality products.
Galaxy Medicare offers a diverse product portfolio that includes surgical dressings, adhesive tapes, POP bandages, compression bandages, orthopedic solutions, and wound care products. These products are marketed under flagship brands such as POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, and FIXCAN.
The company operates through multiple business models:
Manufacturing & Branding for in-house brands.
OEM Services including sourcing, design, and quality testing for other brand owners.
Institutional Sales through government tenders on the GEM Portal.
Exports of medical products across international markets.
With 27 registered trademarks in India, Galaxy Medicare has established strong domestic and global market presence. Its products are widely accepted by the medical community and supplied to government health departments, private hospitals, and corporate healthcare institutions.
The company also holds ISO 9001:2015 and ISO 13485:2016 certifications, ensuring compliance with stringent international quality standards. As of March 2025, the company employs 190 professionals across various departments.
Strengths & Risks of Galaxy Medicare IPO
Experienced Promoters and Skilled Management Team: Galaxy Medicare is backed by seasoned promoters with decades of experience in the healthcare and medical devices industry. Their leadership provides stability and strategic vision for long-term growth.
Established Customer Base: The company has built strong relationships with government institutions, corporate hospitals, and international buyers, ensuring consistent demand and repeat business.
Wide Product Portfolio: Galaxy Medicare offers a diverse range of products, including surgical dressings, orthopedic solutions, POP bandages, adhesive tapes, and wound care items, catering to both domestic and global healthcare needs.
Focus on Quality and Certifications: With ISO 9001:2015 and ISO 13485:2016 certifications, the company emphasizes quality assurance, in-house testing, and R&D. This ensures compliance with international standards and boosts customer trust.
International Market Presence: The company exports its products to global markets, which diversifies revenue sources and reduces dependency on the Indian market alone.
Declining Profitability: Although revenue has grown steadily, the company reported a 9% drop in profit after tax (PAT) in FY25. This could indicate margin pressures and operational challenges.
Dependency on Raw Materials: The business relies heavily on raw material procurement. Any fluctuation in prices or supply chain disruptions can impact production costs and profitability.
Regulatory Compliance Challenges: Being a medical device manufacturer, the company must adhere to stringent domestic and international regulatory norms. Any changes or non-compliance could adversely affect operations.
SME Listing Limitations: Since Galaxy Medicare IPO will be listed on NSE SME, trading volumes and liquidity may be lower compared to mainboard-listed companies, which could affect investor exit opportunities.
Promoter Holding Dilution: Post-IPO, promoter shareholding will decline from 89.49% to 64.60%. Reduced promoter stake may impact control and future decision-making authority.
Galaxy Medicare Financials: Revenue, Profit & EBITDA
N/A
N/A
N/A
How to Apply for Galaxy Medicare IPO: Step-by-Step Guide
- Research the IPO:Review the prospectus and company details.
- Open accounts:Ensure you have a demat and trading account.
- Check dates:Note the IPO opening and closing dates.
- Apply online:Log in to your brokerage account and complete the IPO application form.
- Make payment:Pay through your linked bank account.
- Submit application:Confirm and submit your application.
- Track status:Monitor the allotment status and check for shares in your demat account upon listing.
FAQs: Galaxy Medicare IPO
Active IPOs | |
|---|---|
Company name | Bid starts |
Citius Transnet Investment Trust | 17-04-2026 |